Pfizer starts clinical trials of Covid-19 vaccine among pregnant women

Source : 112 Ukraine

It is planned to vaccinate about 4,000 expectant mothers at 22-24 weeks of pregnancy
12:20, 19 February 2021

American biotech company Pfizer
Sky News

Pfizer Company starts clinical trials of vaccines against Covid-19 among pregnant women as NBC News reported.

It is planned to vaccinate about 4,000 expectant mothers at 22-24 weeks of pregnancy. The trials will be held in the U.S., Argentina, Brazil, Canada, Chile, Mozambique, South Africa, Spain and the UK.

Related: 130 countries have not started vaccination against Covid-19: What are they doing?

Meanwhile, the company stated that some participants will get the vaccine during the trials and some will get a placebo. The researchers will study any negative side effects for women, including miscarriage.

“We are proud to start this study in pregnant women and continue to gather the evidence on safety and efficacy to potentially support the use of the vaccine by important subpopulations," Pfizer representative Dr. William Gruber said.

Related: AstraZeneca vaccine to arrive in Ukraine by end of this week, - Health Minister

As we reported, Pfizer became the fourth company that filed its appeal to register its vaccine against coronavirus in Ukraine. Currently, there are also registration appeals from Sinovac Life Sciences company (China) and Serum Institute of India.


Система Orphus

If you find an error, highlight the desired text and press Ctrl + Enter, to tell about it

see more
latest news
editor's choice